These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 20137136)
1. [Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF]. Zhang J; Zhu JS; Li QR; DU Y; Yang B; Li GX; Hu X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):146-50. PubMed ID: 20137136 [TBL] [Abstract][Full Text] [Related]
2. Differentiation of human umbilical cord blood CD133+ stem cells towards myelo-monocytic lineage. Ruzicka K; Grskovic B; Pavlovic V; Qujeq D; Karimi A; Mueller MM Clin Chim Acta; 2004 May; 343(1-2):85-92. PubMed ID: 15115679 [TBL] [Abstract][Full Text] [Related]
3. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function? Senegaglia AC; Barboza LA; Dallagiovanna B; Aita CA; Hansen P; Rebelatto CL; Aguiar AM; Miyague NI; Shigunov P; Barchiki F; Correa A; Olandoski M; Krieger MA; Brofman PR Exp Biol Med (Maywood); 2010 Jan; 235(1):119-29. PubMed ID: 20404026 [TBL] [Abstract][Full Text] [Related]
4. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Baal N; Reisinger K; Jahr H; Bohle RM; Liang O; Münstedt K; Rao CV; Preissner KT; Zygmunt MT Thromb Haemost; 2004 Oct; 92(4):767-75. PubMed ID: 15467907 [TBL] [Abstract][Full Text] [Related]
5. [Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood]. Wang L; Chen DX; Fang N; Liu ZL; Zhang T; Wan WH; Qi Y; Liu JW Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):645-9. PubMed ID: 18549646 [TBL] [Abstract][Full Text] [Related]
7. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro. Nikolova T; Wu M; Brumbarov K; Alt R; Opitz H; Boheler KR; Cross M; Wobus AM Differentiation; 2007 Feb; 75(2):100-11. PubMed ID: 17316380 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle analysis of the CD133+ and CD133- cells isolated from umbilical cord blood. Grskovic B; Ruzicka K; Karimi A; Qujeq D; Müller MM Clin Chim Acta; 2004 May; 343(1-2):173-8. PubMed ID: 15115691 [TBL] [Abstract][Full Text] [Related]
9. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood. Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071 [TBL] [Abstract][Full Text] [Related]
10. Cord blood-derived neurons are originated from CD133+/CD34 stem/progenitor cells in a cell-to-cell contact dependent manner. Zangiacomi V; Balon N; Maddens S; Lapierre V; Tiberghien P; Schlichter R; Versaux-Botteri C; Deschaseaux F Stem Cells Dev; 2008 Oct; 17(5):1005-16. PubMed ID: 18811243 [TBL] [Abstract][Full Text] [Related]
11. [Isolation and characterization of brain tumor stem cells in human medulloblastoma]. Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595 [TBL] [Abstract][Full Text] [Related]
12. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674 [TBL] [Abstract][Full Text] [Related]
13. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells. Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761 [TBL] [Abstract][Full Text] [Related]
14. Umbilical cord blood cells CD133+/CD133- cultivation in neural proliferation media differentiates towards neural cell lineages. Slovinska L; Novotna I; Kubes M; Radonak J; Jergova S; Cigankova V; Rosocha J; Cizkova D Arch Med Res; 2011 Oct; 42(7):555-62. PubMed ID: 22015230 [TBL] [Abstract][Full Text] [Related]
15. Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells. Bonanno G; Mariotti A; Procoli A; Corallo M; Rutella S; Pessina G; Scambia G; Mancuso S; Pierelli L Transfusion; 2007 Feb; 47(2):280-9. PubMed ID: 17302775 [TBL] [Abstract][Full Text] [Related]
16. [Long-term culture and identification of CD133⁺ hematopoietic progenitor cells from human umbilical cord blood]. Wu XJ; Chen F; Lu YX; Yang H; Peng FL; Yuan L; Liu GB; Li XN Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):349-53. PubMed ID: 22445981 [TBL] [Abstract][Full Text] [Related]
17. [Purification, identification and oriented differentiation of endothelial progenitor cells from human umbilical cord blood]. Xie ST; Chen B; Tao K Zhonghua Shao Shang Za Zhi; 2006 Oct; 22(5):355-8. PubMed ID: 17283881 [TBL] [Abstract][Full Text] [Related]
18. Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells. Zhang C; Zhou C; Wu XJ; Yang M; Yang ZH; Xiong HZ; Zhou CP; Lu YX; Li Y; Li XN Carcinogenesis; 2014 Dec; 35(12):2771-7. PubMed ID: 25269803 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of endothelial cells from human umbilical cord blood AC133-CD14+ cells. Kim SY; Park SY; Kim JM; Kim JW; Kim MY; Yang JH; Kim JO; Choi KH; Kim SB; Ryu HM Ann Hematol; 2005 Jul; 84(7):417-22. PubMed ID: 15711948 [TBL] [Abstract][Full Text] [Related]
20. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]